Market & Alt Data
Buy Activity
Sell Activity
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 2026-10-01 | MORTIMER IAN | Director & PRESIDENT & CEO | Purchase | 30.0K | $37.38 | $1.12M | 49.9K | View | |
| 2026-09-30 | 2026-10-01 | Kelly Thomas Patrick | Chief Financial Officer | Purchase | 15.0K | $37.32 | $560K | 15.0K | View | |
| 2026-08-28 | 2026-08-31 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sale | 7,068 | $60.25 | $426K | 2 | View | |
| 2026-08-11 | 2026-08-13 | GANNON STEVEN | Director | Sale | 10.0K | $64.06 | $641K | 1,870 | View | |
| 2026-03-13 | 2026-03-13 | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | Sale | 1,410 | $55.23 | $78K | 7,069 | View |
Informational purposes only, not investment advice.
tormere.com/research/XENE · generated 2026-10-01
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-30 | MORTIMER IAN | P | 30,000 | $1M |
| 2026-09-30 | Kelly Thomas Patrick | P | 15,000 | $559,740 |
| 2026-08-28 | KENNEY CHRISTOPHER JOHN | S | 700 | $42,683.62 |
| 2026-08-28 | KENNEY CHRISTOPHER JOHN | S | 6,368 | $383,145.37 |
| 2026-08-11 | GANNON STEVEN | S | 10,000 | $640,550 |
Tormere — informational purposes only, not investment advice.